The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?
Patrizia Morbini(University of Pavia), Maurizio Luisetti(University of Pavia), Michele Zorzetto(University of Pavia), Chiara Villa(Centre National de la Recherche Scientifique), Simona Inghilleri(University of Pavia), Ilaria Campo(University of Pavia)
Cited by 156
Related Papers
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340
Pangenomic Classification of Pituitary Neuroendocrine Tumors
|Cancer Cell|2019|335
The 2016 World Health Organization classification of tumours of the central nervous system
|La Presse Médicale|2018|319